Sevoflurane Market with COVID-19 Impact Analysis, By Application (Induction, and Maintenance), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and By Region Size, Share & Forecast from 2022-2028
REPORT HIGHLIGHT
Sevoflurane Market size was valued at USD 374.5 Mn in 2021, growing at a CAGR of 5.3% from 2022 to 2028.
Sevoflurane has been used to induce general anaesthesia both before and during surgery (lack of consciousness). Sevoflurane must be inhaled during administration. Sevoflurane can be used alone, however, it is often coupled with other anaesthetics. This helps certain patients' bodies produce more potent anaesthetics. When compared to other medications on the market, sevoflurane is more potent, acts quickly, and has a quicker emergence and recovery; nevertheless, it is also more expensive. Due to these reasons, surgeons prefer sevoflurane for the induction and maintenance of anaesthesia during surgical procedures. Sevoflurane aids in stabilising the patient's blood pressure and heart rate during surgery. Additionally, sevoflurane can be used to ease pain after surgery.
Market Dynamics
The global sevoflurane market is anticipated to rise with the growth in medical procedures globally.. For instance, throughout the course of the forecast period, an increase in the prevalence of chronic diseases such as cancer, respiratory illnesses, etc. is anticipated to support the expansion of the worldwide sevoflurane market. For instance, according to GLOBOCAN 2020, there were approximately 10.0 million cancer deaths (9.9 million excluding non-melanoma skin cancer) and an estimated 19.3 million new cancer cases globally in 2020. With an estimated 2.3 million new cases, female breast cancer accounted for 11.7% of all cases, followed by lung cancer (11.4%), colorectal cancer (10.0%), prostate cancer (7.3%), and stomach cancer (5.6%) worldwide.
Moreover, the American Society of Plastic Surgeons estimates that in 2020, 6.8 million reconstructive treatments, 13.2 million cosmetic minimally invasive procedures, and 2.3 million cosmetic surgical procedures would be carried out in the United States, a 3 per cent increase over 2019. This demonstrates the increasing number of operations, which ultimately drives up the demand for anaesthetic medications. The majority of medical practitioners now choose sevoflurane over intravenous anaesthesia (IVA) since it avoids unneeded doses and preserves the patient's autonomic capabilities. These drugs have a lesser likelihood of aggregating in the body because they are delivered through the lungs. In comparison to alternative courses, medications managed by respiration in a course have limited resistance and fixation level.
Segmentation Analysis:
The Global Sevoflurane Market is segmented on the basis of Application, Distribution channel and Region.
The market is divided into two categories based on application: Induction and Maintenance. The maintenance segment dominates the global market with a 64% market share. This is because sevoflurane is one of the fastest-acting volatile anaesthetics after desflurane.
The market is divided into three categories based on distribution channels: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. The Hospital pharmacy segment dominates the global market with a 49.4% market share. Inhaled anaesthetic drugs such as Sevoflurane are given to patients after surgery. The entire cost of treating patients is decreased with inhaled anaesthetics. Critically sick patients who have just had surgery are typically admitted to intensive care units, which raises their healthcare costs because hospital stays last longer. Surgery professionals can better plan their dosage with the aid of inhalation anaesthetic. Intravenous anaesthesia, which lowers the patient's overall healthcare costs, prevents this from being achievable.
Competitive Landscape:
The global market for Sevoflurane is made comprises a number of both international and local producers, making it a fairly competitive sector in the world. A key trend among the key market player is the increase in M&As, collaborations, acquisitions, and finance. Companies can quickly broaden their regional reach and current product portfolio through M&A and partnership.
Over the forecast period, the rise is anticipated to be fueled by an increase in the technology launches used to recycle inhaled anaesthetics. For instance, in July 220, ZeoSys Medical, a medical technology company, and Baxter International Inc., a world leader in the manufacture and distribution of sterile drugs, signed a formal partnership to commercialise technology to capture and recycle anaesthetic gases.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SEVOFLURANE MARKET KEY PLAYERS
- Abbott Laboratories
- Baxter
- Piramal Pharma Solutions
- Manus Aktteva Biopharma LLP
- Maruishi Pharmaceutical Co.,Ltd.
- Lunan Pharmaceutical Group
- Abbvie
- Wellona Pharma
- Rewine Pharmaceutical
- Troikaa Pharmaceutical
GLOBAL SEVOFLURANE MARKET, BY APPLICATION
- Induction
- Maintenance
GLOBAL SEVOFLURANE MARKET, BY DISTRIBUTION CHANNEL
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
GLOBAL SEVOFLURANE MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Sevoflurane Market Overview
1.1. Study Scope
2. Executive Summary
2.1. Market Snippet
2.1.1. Market Snippet by Distribution Channel
2.1.2. Market Snippet by Application
2.1.3. Market Snippet by Country
2.1.4. Market Snippet by Region
2.2. Competitive Insights
3. Sevoflurane Key Market Trends
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. Sevoflurane Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Sevoflurane Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Sevoflurane Market Landscape
6.1. Market Share Analysis, 2021
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Sevoflurane Market – By Distribution Channel
7.1. Overview
7.1.1. Segment Share Analysis, By Distribution Channel, 2021 & 2028 (%)
7.1.2. Hospital Pharmacies
7.1.3. Retail Pharmacies
7.1.4. Online Pharmacies
8. Sevoflurane Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2021 & 2028 (%)
8.1.2. Induction
8.1.3. Maintenance
9. Sevoflurane Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2021 & 2028 (%)
9.2. North America
9.2.1. Overview
9.2.2. Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
9.2.4. North America Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.2.5. North America Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.3.5. Europe Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.3.7. Italy
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.7.3. Italy Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.3.7.4. Italy Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.3.8. United Kingdom
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.8.3. United Kingdom Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.3.9. France
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.9.3. France Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.3.9.4. France Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.3.10. Russia
9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.10.2. Russia Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.3.10.3. Russia Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.3.11. Netherlands
9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.11.2. Netherlands Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.3.11.3. Netherlands Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.3.12. Sweden
9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.12.2. Sweden Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.3.12.3. Sweden Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.3.13. Poland
9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.13.2. Poland Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.3.13.3. Poland Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.3.14. Rest of Europe
9.3.14.1. Overview
9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.14.3. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.4.6.4. India Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.4.7.4. China Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.8.3. Japan Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.4.8.4. Japan Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.4.9. South Korea
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.9.3. South Korea Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.4.9.4. South Korea Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.4.11. Thailand
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.11.3. Thailand Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.4.11.4. Thailand Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.4.12. Indonesia
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.12.3. Indonesia Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.4.12.4. Indonesia Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
10. Key Vendor Analysis
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Abbott Laboratories
10.2.2. Baxter
10.2.3. Piramal Pharma Solutions
10.2.4. Manus Aktteva Biopharma LLP
10.2.5. Maruishi Pharmaceutical Co.,Ltd.
10.2.6. Lunan Pharmaceutical Group
10.2.7. Abbvie
10.2.8. Wellona Pharma
10.2.9. Rewine Pharmaceutical
10.2.10. Troikaa Pharmaceutical
11. 360 Degree Analyst View
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
